A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer’s and other neurodegenerative diseases.
Pharmaceutical Sciences Division
Designing a Better Approach to Monitor Cancer
Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
Study Identifies Promising Target for Treating Inflammatory Bowel Disease and Colitis-Induced Colorectal Cancers
Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.
Defeating Antibiotic Resistance
Armed with two new grants, School of Pharmacy Assistant Professor Jason Peters continues his quest to find new targets for the hardest-to-treat bacterial infections.
How Traumatic Stress Changes the Brain
New research by School of Pharmacy Professor Lingjun Li uncovers the role of neuropeptides in post-traumatic stress disorder.
Jason Kwan Receives 2023 Matt Suffness Young Investigator Award
For his innovative research of natural products, Associate Professor Jason Kwan is being nationally recognized by the American Society of Pharmacognosy.
Playing Forensic Toxicology ‘Whack-a-Mole’
School of Pharmacy Assistant Professor Heather Barkholtz is working to deepen our understanding of new drugs of abuse and how to detect them.
Brain-Penetrating Drug Candidate Effective Against Deadly Encephalitis Viruses
A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
New Drug Delivery Method Harnesses Clotting to Target Anti-Cancer Drugs at Tumors
Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
Preventing the Next Pandemic
From COVID-19 to encephalitic alphaviruses, School of Pharmacy Associate Professor Jennifer Golden and collaborators are developing new antiviral treatments.